These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10719072)

  • 1. Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors.
    Shiotani T; Nakamoto Y; Watabe S; Yoshii M; Nabeshima T
    Brain Res; 2000 Mar; 859(2):255-61. PubMed ID: 10719072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nootropic nefiracetam inhibits proconvulsant action of peripheral-type benzodiazepines in epileptic mutant EL mice.
    Nakamoto Y; Shiotani T; Watabe S; Nabeshima T; Yoshii M
    Ann N Y Acad Sci; 2004 Oct; 1025():135-9. PubMed ID: 15542710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice.
    Nakamoto Y; Watabe S; Shiotani T; Yoshii M
    Brain Res; 1996 Apr; 717(1-2):91-8. PubMed ID: 8738258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice.
    Rashid MH; Ueda H
    J Pharmacol Exp Ther; 2002 Oct; 303(1):226-31. PubMed ID: 12235255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels.
    Yoshii M; Watabe S; Murashima YL; Nukada T; Shiotani T
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S95-102. PubMed ID: 10850736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
    Nomura T; Nishizaki T
    Brain Res; 2000 Jul; 870(1-2):157-62. PubMed ID: 10869513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mitochondrial benzodiazepine receptors (MBR) in association with neurological disorders].
    Yoshii M; Nakamoto Y; Watabe S; Mugishima G; Habu H; Shiotani T; Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Apr; 18(2):49-54. PubMed ID: 9656233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
    Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S
    Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex.
    Basile AS; Weissman BA; Skolnick P
    Brain Res Bull; 1987 Jul; 19(1):1-7. PubMed ID: 2820550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peripheral-type benzodiazepine receptor is present in astrocytes but is not a primary site of action for convulsants/anticonvulsants.
    Moynagh PN; Schousboe A; Williams DC
    J Neurochem; 1994 Feb; 62(2):673-9. PubMed ID: 8294930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
    Zhao X; Kuryatov A; Lindstrom JM; Yeh JZ; Narahashi T
    Mol Pharmacol; 2001 Apr; 59(4):674-83. PubMed ID: 11259610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Peripheral-type" binding sites for benzodiazepines in brain: relationship to the convulsant actions of Ro 5-4864.
    Weissman BA; Cott J; Jackson JA; Bolger GT; Weber KH; Horst WD; Paul SM; Skolnick P
    J Neurochem; 1985 May; 44(5):1494-9. PubMed ID: 2580949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors.
    Zhao X; Yeh JZ; Narahashi T
    Ann N Y Acad Sci; 2001 Jun; 939():179-86. PubMed ID: 11462769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Satoh H; Aoki T; Kinoshita M; Takazawa A; Yamauchi T; Sakurada S
    Brain Res; 2005 Sep; 1057(1-2):168-76. PubMed ID: 16122714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5-4864.
    Pellow S; File SE
    J Pharm Pharmacol; 1985 Aug; 37(8):560-3. PubMed ID: 2864417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anti-convulsant properties of PK 11195, a ligand for benzodiazepine binding sites: development of tolerance.
    File SE
    Br J Pharmacol; 1984 Oct; 83(2):471-6. PubMed ID: 6091832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RO 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice.
    Haigh JR; Feely M
    Eur J Pharmacol; 1988 Mar; 147(2):283-5. PubMed ID: 2835250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and pharmacological actions of the convulsant benzodiazepine Ro 5-4864.
    Weissman BA; Cott J; Hommer D; Paul S; Skolnick P
    Eur J Pharmacol; 1984 Jan; 97(3-4):257-63. PubMed ID: 6323193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
    Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K
    J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.